Study Evaluating Rhapsody Registry in Patients With Depression and Anxiety

This study has been completed.
Information provided by:
Wyeth is now a wholly owned subsidiary of Pfizer Identifier:
First received: October 17, 2005
Last updated: March 14, 2007
Last verified: March 2007

The purpose of this study is to assess the prevalence of Major Depression and/or Anxiety Disorder in patients consulting the General Practitioner with acute or chronic painful physical symptoms and to identify risk factors.

Anxiety Disorder

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Official Title: An Observational Study on the Presence of Depression and/or Anxiety Disorder in Patients Consulting the General Practitioner With Painful Physical Symptoms in Belgium and Luxemburg.

Resource links provided by NLM:

Further study details as provided by Wyeth is now a wholly owned subsidiary of Pfizer:

Estimated Enrollment: 2560
Study Start Date: November 2005

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Outpatient must be at least 18 years of age
  • Consulting a General Practitioner for painful physical symptoms
  • Written informed consent

Exclusion Criteria:

  • Patient is unable to understand and comply with procedures of the study
  • Patient is unable to complete the patient ratings
  • Patient has an acute pain with an obvious cause
  Contacts and Locations
Please refer to this study by its identifier: NCT00241397

  Show 91 Study Locations
Sponsors and Collaborators
Wyeth is now a wholly owned subsidiary of Pfizer
Study Director: Medical Monitor, MD Wyeth is now a wholly owned subsidiary of Pfizer
Principal Investigator: Trial Manager For Belgium,
  More Information

No publications provided Identifier: NCT00241397     History of Changes
Other Study ID Numbers: 0600B1-102003
Study First Received: October 17, 2005
Last Updated: March 14, 2007
Health Authority: Belgium: Institutional Review Board

Keywords provided by Wyeth is now a wholly owned subsidiary of Pfizer:
anxiety disorder

Additional relevant MeSH terms:
Anxiety Disorders
Depressive Disorder
Mental Disorders
Behavioral Symptoms
Mood Disorders processed this record on April 16, 2014